Asia-Pacific Influenza Vaccines Market 2019-2028

MARKET OUTLOOK

According to an analysis, the influenza vaccines market in Asia-Pacific is likely to flourish at a CAGR of 6.63% in the projected period 2019-2028.
Australia & New Zealand, South Korea, India, China, Japan, ASEAN countries and the Rest of APAC together form the Asia-Pacific’s influenza vaccines market.

The high prevalence of influenza, rising healthcare expenditure and enhancements in healthcare access in countries like India and China are primarily driving the growth of the influenza vaccines market. For example, the Department of Biotechnology, Government of India and the European Commission, have together launched a flagship call on the next generation influenza vaccine. Both these organizations have committed a funding of EUR 15 million for the joint project proposals. These rising initiatives by the government regarding the development programs of the influenza vaccine are contributing to the growth of the influenza vaccines market.

There are subsidized immunization programs conducted primarily for the aged population in countries like Japan, South Korea and Australia, which is contributing towards the regional market growth. Also, the growing demand for effective vaccines that can prevent diseases like influenza is also instigating the market growth in Asia-Pacific. The escalating birth rates and aging population, coupled with the rising awareness among the people regarding the vaccine in India and China, are helping increased demand for the influenza vaccine in the region in the next few years.

COMPETITIVE OUTLOOK

The major players in the influenza vaccines market are GlaxoSmithKline Plc, CSL Limited, Abbott, Sanofi and BioDiem.

1. Asia-Pacific Influenza Vaccines Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Quadrivalent is the Dominant Type of Influenza Vaccine
2.2.2. Injection is Fastest-Growing Delivery Mode
2.2.3. Cell-Based Technology is Rapidly Growing Technology in the Market
2.2.4. Adult Age Group is Majorly Contributing in the Market
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Intensity of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Advancement in Technology
2.6.2. Initiatives Taken Up by the Government
2.7. Market Restraints
2.7.1. High Cost of Development
2.8. Market Opportunities
2.8.1. Growth in the Cases of Influenza
2.9. Market Challenges
2.9.1. Complex Development Process

3. Influenza Vaccines Market Outlook - by Type

3.1. Quadrivalent Vaccine
3.2. Trivalent Vaccine

4. Influenza Vaccines Market Outlook - by Technology

4.1. Egg-Based Technology
4.2. Cell-Based Technology

5. Influenza Vaccines Market Outlook - by Age Group

5.1. Pediatric Age Group
5.2. Adult Age Group

6. Influenza Vaccines Market Outlook - by Delivery Mode

6.1. Injection
6.2. Nasal Spray

7. Influenza Vaccines Market – Asia-Pacific

7.1. China
7.2. Japan
7.3. India
7.4. South Korea
7.5. Asean Countries
7.6. Australia & New Zealand
7.7. Rest of Asia-Pacific

8. Competitive Landscape

8.1. Merck Sharp & Dohme Corp
8.2. Novartis AG
8.3. Pfizer Inc
8.4. Sanofi
8.5. Biodiem
8.6. Emergent Biosolutions Inc
8.7. F. Hoffmann-La Roche Ltd
8.8. GlaxoSmithKline plc
8.9. Abbott
8.10. CSL Limited

9. Research Methodology & Scope

9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables

Table 1: Asia-Pacific Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Asia-Pacific Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 4: Asia-Pacific Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 5: Asia-Pacific Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 6: Asia-Pacific Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)
Table 7: Asia-Pacific Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)

List of Figures

Figure 1: Asia-Pacific Influenza Vaccines Market, by Source, 2019 & 2028 (In %)
Figure 2: Asia-Pacific Quadrivalent Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 3: Asia-Pacific Injection Delivery Model Market, 2019-2028 (In $ Million)
Figure 4: Asia-Pacific Cell-Based Technology Market, 2019-2028 (In $ Million)
Figure 5: Asia-Pacific Adult Age Group Market, 2019-2028 (In $ Million)
Figure 6: Porter's Five Force Analysis
Figure 7: Market Attractiveness Index
Figure 8: Asia-Pacific Influenza Vaccines Market, by Quadrivalent Vaccine, 2019-2028 (In $ Million)
Figure 9: Asia-Pacific Influenza Vaccines Market, by Trivalent Vaccines, 2019-2028 (In $ Million)
Figure 10: Asia-Pacific Influenza Vaccines Market, by Egg-Based Technology, 2019-2028 (In $ Million)
Figure 11: Asia-Pacific Influenza Vaccines Market, by Cell-Based Technology, 2019-2028 (In $ Million)
Figure 12: Asia-Pacific Influenza Vaccines Market, by Pediatric Age Group, 2019-2028 (In $ Million)
Figure 13: Asia-Pacific Influenza Vaccines Market, by Adult Age Group, 2019-2028 (In $ Million)
Figure 14: Asia-Pacific Influenza Vaccines Market, by Injection, 2019-2028 (In $ Million)
Figure 15: Asia-Pacific Influenza Vaccines Market, by Nasal Spray, 2019-2028 (In $ Million)
Figure 16: Asia-Pacific Influenza Vaccines Market, Regional Outlook, 2019 & 2028 (In %)
Figure 17: China Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 18: Japan Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 19: India Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 20: South Korea Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 21: Asean Countries Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 22: Australia & New Zealand Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 23: Rest of Asia-Pacific Influenza Vaccines Market, 2019-2028 (In $ Million)